Telix Pharmaceuticals (TLPPF) Shares Outstanding (2023 - 2026)

Telix Pharmaceuticals (TLPPF) has reported Shares Outstanding (Entity) for 3 consecutive years, with $338.8 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 1.21% year-over-year to $338.8 million in Q4 2025; TTM through Dec 2025 was $338.8 million, a 1.21% increase from a year earlier, with the FY2025 full-year figure at $338.8 million, up 1.21% from the prior year.
• Shares Outstanding (Entity) was $338.8 million for Q4 2025 at Telix Pharmaceuticals, up from $334.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $338.8 million in Q4 2025 and troughed at $323.7 million in Q4 2023.
• A 3-year average of $332.4 million and a median of $334.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) increased 3.4% in 2024 and grew 1.21% in 2025, its largest moves.
• Over 3 years, Shares Outstanding (Entity) stood at $323.7 million in 2023, then gained by 3.4% to $334.7 million in 2024, then grew by 1.21% to $338.8 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $338.8 million (Q4 2025), $334.7 million (Q4 2024), and $323.7 million (Q4 2023), per Business Quant data.